The central role of ferroptosis-induced therapy mediated by tenacissoside H in anaplastic thyroid cancer

Bibliographic Data

ID14728057
AuthorsWanwan He (0009-0005-0261-3665), Xiaotian Hu (0000-0001-9618-8447, Shanghai First People's Hospital), Minghua Ge (0000-0001-6726-6418, Zhejiang Cancer Hospital, corresponding author), Kexin Meng (0000-0002-6590-6327, Zhejiang Cancer Hospital, corresponding author)
Year2025
Volume348
Pages119908
Publication date2025-05-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2025.119908
PMID40311717
OpenAlexW4409907394
LanguageEN
References cited31

TDH could be considered a potential agent against ATC via inducing ferroptosis, providing a novel pharmacological basis for treating ATC

Anaplastic thyroid cancer · Cancer · Cancer Therapy · Thyroid · Thyroid cancer · Cancer-related molecular mechanisms research · Cancer, Lipids, and Metabolism · Ferroptosis and cancer prognosis · Medicine · Cancer Research · Internal Medicine · Oncology · Pharmacology

Tools

Open DOIOpen Access